Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CrossAmerica Partners LP Unit | CAPL | Oct 30, 2024 | 21.41 | +2.10 |
CrossFirst Bankshares | CFB | Oct 30, 2024 | 16.17 | +0.75 |
CrowdStrike A | CRWD | Oct 30, 2024 | 307.45 | -1.12 |
Crown Castle | CCI | Oct 30, 2024 | 107.81 | +1.13 |
Crown Crafts | CRWS | Oct 30, 2024 | 4.63 | +0.87 |
Crown ElectroKinetics | CRKN | Oct 30, 2024 | 0.89 | -13.11 |
Crown Holdings | CCK | Oct 30, 2024 | 95.68 | +1.00 |
Crown LNG | CGBS | Oct 30, 2024 | 0.29 | -0.81 |
Cryo-Cell International | CCEL | Oct 30, 2024 | 7.31 | +25.60 |
CryoPort | CYRX | Oct 30, 2024 | 6.81 | -5.42 |
CS Disco | LAW | Oct 30, 2024 | 5.95 | -1.49 |
CSG Systems International | CSGS | Oct 30, 2024 | 47.29 | -0.69 |
CSP | CSPI | Oct 30, 2024 | 12.52 | +1.05 |
CSW Industrials | CSWI | Oct 30, 2024 | 360.09 | -0.85 |
CSX | CSX | Oct 30, 2024 | 33.54 | +0.87 |
CTO Realty Growth | CTO | Oct 30, 2024 | 19.52 | +1.61 |
CTO Realty Growth A Pref | CTO-A | Oct 30, 2024 | 24.15 | -0.21 |
CTS | CTS | Oct 30, 2024 | 50.78 | +2.11 |
CubeSmart | CUBE | Oct 30, 2024 | 48.27 | +1.28 |
Cue Biopharma | CUE | Oct 30, 2024 | 1.75 | +3.55 |
Cullen Frost Bankers B Pref | CFR-B | Oct 30, 2024 | 20.10 | -1.03 |
Cullen/Frost Bankers | CFR | Oct 30, 2024 | 130.47 | +0.52 |
Cullinan Therapeutics | CGEM | Oct 30, 2024 | 16.22 | -4.14 |
Cullman Bancorp | CULL | Oct 30, 2024 | 9.71 | 0.00 |
Culp | CULP | Oct 30, 2024 | 5.42 | -1.09 |
Cumberland Pharmaceuticals | CPIX | Oct 30, 2024 | 1.19 | -4.03 |
Cummins | CMI | Oct 30, 2024 | 331.84 | +0.21 |
Cumulus Media A | CMLS | Oct 30, 2024 | 1.17 | +0.43 |
Curbline Properties Corp. When Issued | CURB | Oct 30, 2024 | 23.41 | 0.00 |
Curevac N.V. | CVAC | Oct 30, 2024 | 2.80 | -3.11 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.